Zobrazeno 1 - 10
of 278
pro vyhledávání: '"F. Cerino"'
Autor:
M. Bordiga, C. Lupi, G. Langer, A. Gianoncelli, G. Birarda, S. Pollastri, V. Bonanni, D. E. Bedolla, L. Vaccari, G. Gariani, F. Cerino, M. Cabrini, A. Beran, M. Zuccotti, G. Fiorentino, M. Zanoni, S. Garagna, M. Cobianchi, A. Di Giulio
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Coccolithophores, marine calcifying phytoplankton, are important primary producers impacting the global carbon cycle at different timescales. Their biomineral structures, the calcite containing coccoliths, are among the most elaborate hard p
Externí odkaz:
https://doaj.org/article/ea3bd106f8584256be15bf93bd642654
Autor:
J. de Vries, F. Monteiro, G. Wheeler, A. Poulton, J. Godrijan, F. Cerino, E. Malinverno, G. Langer, C. Brownlee
Publikováno v:
Biogeosciences, Vol 18, Pp 1161-1184 (2021)
Coccolithophores are globally important marine calcifying phytoplankton that utilize a haplo-diplontic life cycle. The haplo-diplontic life cycle allows coccolithophores to divide in both life cycle phases and potentially expands coccolithophore nich
Externí odkaz:
https://doaj.org/article/b499e950d7fe475d9fabe5cfac823291
Autor:
L. A. Pedrini, A. C. Winter, F. Cerino, A. M. Zawada, M. Garbelli, A. Feuersenger, A. Feliciani, P. Ruggiero, S. Civardi, C. Amato, B. Canaud, S. Stuard, A. Karch, A. Gauly
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Innovative care models such as public-private partnerships (PPPs) may help meet the challenge of providing cost-effective high-quality care for the steadily growing and complex chronic kidney disease population since they combine
Externí odkaz:
https://doaj.org/article/ae4b0381046949098cfba2c0bf9f4e75
Autor:
Bernard Canaud, Adelheid Gauly, L. A. Pedrini, Adam M Zawada, Astrid Feuersenger, F. Cerino, Stefano Stuard, A. Feliciani, Claudia Amato, Anke Winter, P. Ruggiero, A. Karch, S. Civardi, Mario Garbelli
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-11 (2019)
BMC Nephrology
BMC Nephrology, BioMed Central, 2019, 20, pp.35. ⟨10.1186/s12882-019-1224-2⟩
BMC Nephrology
BMC Nephrology, BioMed Central, 2019, 20, pp.35. ⟨10.1186/s12882-019-1224-2⟩
Background Innovative care models such as public-private partnerships (PPPs) may help meet the challenge of providing cost-effective high-quality care for the steadily growing and complex chronic kidney disease population since they combine the exper
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L. Pedrini, A. Winter, F. Cerino, A. Zawada, M. Garbelli, A. Feuersenger, A. Feliciani, P. Ruggiero, S. Civardi, C. Amato, B. Canaud, S. Stuard, A. Karch, A. Gauly
Table S3. Cumulative numbers of deaths, competing events and censored events in prevalent and incident patients every 6â months throughout the study period. This table provides additional information to Table 5 and Fig. 1. (PDF 24 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ff8e7c3df56b75bb7c61b8920a1a513
Autor:
L. Pedrini, A. Winter, F. Cerino, A. Zawada, M. Garbelli, A. Feuersenger, A. Feliciani, P. Ruggiero, S. Civardi, C. Amato, B. Canaud, S. Stuard, A. Karch, A. Gauly
Figure S1. Study design and definition of prevalent and incident patients. This figure illustrates the design of the study and visualizes how prevalent and incident patients were defined. The renal-replacement therapy initiation date was before 1 Oct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::243c9a26a4b43d203c69e87ddb437888
Autor:
L. Pedrini, A. Winter, F. Cerino, A. Zawada, M. Garbelli, A. Feuersenger, A. Feliciani, P. Ruggiero, S. Civardi, C. Amato, B. Canaud, S. Stuard, A. Karch, A. Gauly
Table S1. Cause of renal disease of the study patients. This table provides information about the number and percentages of underling renal disease of the study participants. (PDF 17 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc90a4dded53c25cfb2b7caa9ebd909
Autor:
L. Pedrini, A. Winter, F. Cerino, A. Zawada, M. Garbelli, A. Feuersenger, A. Feliciani, P. Ruggiero, S. Civardi, C. Amato, B. Canaud, S. Stuard, A. Karch, A. Gauly
Table S2. Use of medication at least once during the study period. This table provides information about the medication use in our study population during the study period. (PDF 18 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b2c14005d46bf0169a0dd5a01496f20